TABLE 5.
Impact of treatment on exacerbations and health care utilization during the study period
| Tiotropium, n=608 | Placebo, n=305 | P | |
|---|---|---|---|
| Patients with ≥1 exacerbation, % | 44.1 | 41.0 | 0.395 |
| Number of exacerbations | 0.88 | 0.92 | 0.599 |
| Number of exacerbation days | 16.1 | 16.2 | 0.843 |
| Patients with ≥1 hospitalization, % | 8.4 | 8.2 | 1.000 |
| Number of hospitalizations | 0.13 | 0.15 | 0.557 |
| Number of hospitalization days | 1.14 | 1.16 | 0.775 |
| Number of courses of oral steroids | 0.58 | 0.55 | 0.599 |
| Number of courses of antibiotics | 1.02 | 1.00 | 0.756 |
Expressed as events per patient-year, unless otherwise indicated